0.5168
price down icon8.09%   -0.0455
after-market Dopo l'orario di chiusura: .53 0.0132 +2.55%
loading
Precedente Chiudi:
$0.5623
Aprire:
$0.56
Volume 24 ore:
64,778
Relative Volume:
0.33
Capitalizzazione di mercato:
$3.02M
Reddito:
$14.64M
Utile/perdita netta:
$-13.74M
Rapporto P/E:
-0.0711
EPS:
-7.27
Flusso di cassa netto:
$-5.04M
1 W Prestazione:
-15.00%
1M Prestazione:
-17.63%
6M Prestazione:
-27.21%
1 anno Prestazione:
-85.88%
Intervallo 1D:
Value
$0.501
$0.56
Intervallo di 1 settimana:
Value
$0.501
$0.6096
Portata 52W:
Value
$0.3611
$9.079

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name
Nome
Novabay Pharmaceuticals Inc
Name
Telefono
510-899-8800
Name
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Name
Dipendente
86
Name
Cinguettio
@NovaBayPharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
NBY's Discussions on Twitter

Confronta NBY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NBY
Novabay Pharmaceuticals Inc
0.5168 3.02M 14.64M -13.74M -5.04M -7.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 26.46B 3.81B -644.79M -669.77M -6.24

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2019-09-18 Iniziato Ladenburg Thalmann Buy
2018-07-06 Reiterato H.C. Wainwright Buy
2017-11-15 Reiterato Laidlaw Buy
2017-06-05 Iniziato ROTH Capital Buy
2017-03-27 Iniziato Laidlaw Buy
2017-02-06 Iniziato Rodman & Renshaw Buy
2016-03-07 Downgrade Maxim Group Buy → Hold
2015-12-14 Reiterato Maxim Group Buy
2015-04-30 Ripresa Maxim Group Buy
2013-03-06 Iniziato Ascendiant Capital Markets Strong Buy
2008-01-03 Iniziato Dawson James Speculative Buy
Mostra tutto

Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie

pulisher
Apr 01, 2025

NovaBay Pharmaceuticals Delays Yearly Report Filing - TipRanks

Apr 01, 2025
pulisher
Mar 28, 2025

CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga

Mar 28, 2025
pulisher
Mar 27, 2025

Revolutionizing Healing: Trends in the Advanced Wound Care Market with NovaBay, Healthy.io - openPR.com

Mar 27, 2025
pulisher
Mar 24, 2025

Blepharitis Treatment Market Future Business Opportunities - openPR.com

Mar 24, 2025
pulisher
Mar 18, 2025

NovaBay Pharmaceuticals (NBY) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decrease in Short Interest - Defense World

Mar 18, 2025
pulisher
Mar 12, 2025

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Share Price Passes Above 50-Day Moving Average – Time to Sell? - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

NovaBay reaches settlements over disputed warrants By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

NovaBay reaches settlements over disputed warrants - Investing.com India

Mar 11, 2025
pulisher
Mar 08, 2025

NovaBay Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 07, 2025

Novabay Pharmaceuticals Engages Financial Advisor Should Stockholders Fail To Approve Dissolution Proposal - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire

Mar 07, 2025
pulisher
Mar 06, 2025

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update - Defense World

Mar 06, 2025
pulisher
Mar 01, 2025

StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World

Mar 01, 2025
pulisher
Feb 27, 2025

Investor Network: NovaBay Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

NovaBay's Avenova Highlighted in National Dry Eye Awareness Month - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 21, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 21, 2025
pulisher
Feb 17, 2025

NovaBay extends CEO's contract through 2025 - MSN

Feb 17, 2025
pulisher
Feb 13, 2025

StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World

Feb 13, 2025
pulisher
Feb 08, 2025

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Crosses Above Fifty Day Moving Average – Time to Sell? - Armenian Reporter

Feb 08, 2025
pulisher
Feb 06, 2025

NovaBay fails to gain shareholder approval for dissolution - MSN

Feb 06, 2025
pulisher
Feb 05, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by Analysts at StockNews.com - ETF Daily News

Feb 05, 2025
pulisher
Feb 04, 2025

NovaBay fails to gain shareholder approval for dissolution By Investing.com - Investing.com Canada

Feb 04, 2025
pulisher
Jan 28, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.com - Defense World

Jan 28, 2025
pulisher
Jan 25, 2025

**NovaBay Pharmaceuticals Completes Asset Sale Transaction and Plans for Dissolution**** - Defense World

Jan 25, 2025
pulisher
Jan 24, 2025

NovaBay Pharmaceuticals Completes the Sale of its Avenova Eyecare Business to PRN, Seeks Full Company Dissolution - Vision Monday

Jan 24, 2025
pulisher
Jan 23, 2025

NovaBay Pharma’s Strategic Shift and Liquidation Plans - TipRanks

Jan 23, 2025
pulisher
Jan 23, 2025

NovaBay Completes $11.5M Avenova Sale to PRN, Pursues Full Company Dissolution - StockTitan

Jan 23, 2025
pulisher
Jan 23, 2025

NovaBay Pharmaceuticals Extends CEO’s Employment Agreement Until 2025 - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

NovaBay extends CEO's contract through 2025 By Investing.com - Investing.com South Africa

Jan 22, 2025
pulisher
Jan 20, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 20, 2025
pulisher
Jan 12, 2025

NovaBay Pharmaceuticals Completes Sale of Wound Care Product Trademarks and Inventory - Defense World

Jan 12, 2025
pulisher
Dec 30, 2024

Novabay Pharmaceuticals Announces Board Changes - Marketscreener.com

Dec 30, 2024
pulisher
Dec 28, 2024

NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Dec 28, 2024
pulisher
Dec 27, 2024

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Cross Above 50 Day Moving Average – Should You Sell? - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews.com - Defense World

Dec 27, 2024
pulisher
Dec 25, 2024

NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why - Yahoo Finance

Dec 25, 2024
pulisher
Dec 21, 2024

NovaBay Pharmaceuticals Adjourns Special Meeting Due to Insufficient Votes - Defense World

Dec 21, 2024
pulisher
Dec 19, 2024

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - BioSpace

Dec 19, 2024
pulisher
Dec 19, 2024

NovaBay Pharmaceuticals Delays Critical Vote on Avenova Sale and Company Dissolution Amid Vote Shortage - StockTitan

Dec 19, 2024
pulisher
Dec 15, 2024

NovaBay®Pharmaceuticals, Inc. Launches NovaWipes Eyelid Wipes on Amazon.com - Marketscreener.com

Dec 15, 2024
pulisher
Dec 10, 2024

NBYNovaBay Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Dec 10, 2024
pulisher
Dec 09, 2024

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - BioSpace

Dec 09, 2024

Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):